awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24658031-38CF258B-E318-486F-B23E-64ED01695900
Q24658031-38CF258B-E318-486F-B23E-64ED01695900
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658031-38CF258B-E318-486F-B23E-64ED01695900
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders
P2860
Q24658031-38CF258B-E318-486F-B23E-64ED01695900
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658031-38CF258B-E318-486F-B23E-64ED01695900
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14f8b602b5130334281144c1dc3a1e5550e8a4e7
P2860
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.